American College of Gastroenterology

Based in VA

🤖

AI Overview

With $1.4M in lobbying spend across 30 quarterly filings, American College of Gastroenterology is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.

$1.4M
Total Spend
8
Years Active
1
Firms Hired
9
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$150K
2019$250K
2020$200K
2021$190K
2022$130K
2023$180K
2024$130K
2025$180K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Small Business, Budget/Appropriations

The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general; H.R. 3726, Stark Administrative Simplification Act; H.R. 3120, to amend Title XVIII of the Social Security Act to reduce the value of future electronic health record-related significant hardship requests; Pub. Law 115-123, Section 51003, regarding technical amendments to Pub. Law 114-10.

Issues regarding Medical Liability Reform under H.R.1565, Saving Lives, Saving Costs Act.

Issues regarding Medical Liability Reform under H.R.1565, Saving Lives, Saving Costs Act; H.R.2077, Restoring the Patients Voice Act of 2017.

Restoring Patients Voice Act (115th Cong.)

The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general; Pub. Law 115-123, Section 51003, regarding technical amendments to Pub. Law 114-10; H.R. 1570/S. 668, The Removing Barriers to Colorectal Cancer Screening Act of 2019.

The Safe Step Act, H.R. 2279; Surprise Billing Legislation, in general; Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1531; Protecting People From Surprise Medical Bills Act, H.R. 3502; No Surprises Act, H.R. 3630; Lower Health Care Costs Act, S.1895.

The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general; Pub. Law 115-123, Section 51003, regarding technical amendments to Pub. Law 114-10; H.R. 1570/S. 668, The Removing Barriers to Colorectal Cancer Screening Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.

The Safe Step Act, H.R. 2279; Surprise Billing Legislation, in general; Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1531; Protecting People From Surprise Medical Bills Act, H.R. 3502; No Surprises Act, H.R. 3630; Lower Health Care Costs Act, S.1895; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting GI patients, physicians and ambulatory surgery centers.

Showing 8 of 20 unique descriptions from filings.

Related Analysis

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.